These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 30423435

  • 1. Population pharmacokinetic modeling to establish the role of P-glycoprotein on ciprofloxacin distribution to lung and prostate following intravenous and intratracheal administration to Wistar rats.
    Zimmermann ES, de Miranda Silva C, Neris C, Torres BGDS, Schmidt S, Dalla Costa T.
    Eur J Pharm Sci; 2019 Jan 15; 127():319-329. PubMed ID: 30423435
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Population Pharmacokinetic Modeling as a Tool To Characterize the Decrease in Ciprofloxacin Free Interstitial Levels Caused by Pseudomonas aeruginosa Biofilm Lung Infection in Wistar Rats.
    Torres BGS, Helfer VE, Bernardes PM, Macedo AJ, Nielsen EI, Friberg LE, Dalla Costa T.
    Antimicrob Agents Chemother; 2017 Jul 15; 61(7):. PubMed ID: 28461311
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New aerosol formulation to control ciprofloxacin pulmonary concentration.
    Lamy B, Tewes F, Serrano DR, Lamarche I, Gobin P, Couet W, Healy AM, Marchand S.
    J Control Release; 2018 Feb 10; 271():118-126. PubMed ID: 29277683
    [Abstract] [Full Text] [Related]

  • 8. Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis.
    Hurtado FK, Weber B, Derendorf H, Hochhaus G, Dalla Costa T.
    Antimicrob Agents Chemother; 2014 Feb 10; 58(2):678-86. PubMed ID: 24217697
    [Abstract] [Full Text] [Related]

  • 9. Model Calculations of Regional Deposition and Disposition for Single Doses of Inhaled Liposomal and Dry Powder Ciprofloxacin.
    Martin AR, Finlay WH.
    J Aerosol Med Pulm Drug Deliv; 2018 Feb 10; 31(1):49-60. PubMed ID: 28708440
    [Abstract] [Full Text] [Related]

  • 10. Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin.
    Rohwedder R, Bergan T, Caruso E, Thorsteinsson SB, Della Torre H, Scholl H.
    Chemotherapy; 1991 Feb 10; 37(4):229-38. PubMed ID: 1790720
    [Abstract] [Full Text] [Related]

  • 11. Central nervous system pharmacokinetics of the Mdr1 P-glycoprotein substrate CP-615,003: intersite differences and implications for human receptor occupancy projections from cerebrospinal fluid exposures.
    Venkatakrishnan K, Tseng E, Nelson FR, Rollema H, French JL, Kaplan IV, Horner WE, Gibbs MA.
    Drug Metab Dispos; 2007 Aug 10; 35(8):1341-9. PubMed ID: 17470526
    [Abstract] [Full Text] [Related]

  • 12. In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.
    Ong HX, Benaouda F, Traini D, Cipolla D, Gonda I, Bebawy M, Forbes B, Young PM.
    Eur J Pharm Biopharm; 2014 Jan 10; 86(1):83-9. PubMed ID: 23851077
    [Abstract] [Full Text] [Related]

  • 13. Determination of the concentration of ciprofloxacin in prostate tissue following administration of a single, 1000 mg, extended-release dose.
    Lugg J, Lettieri J, Stass H, Agarwal V.
    J Chemother; 2008 Apr 10; 20(2):213-8. PubMed ID: 18467248
    [Abstract] [Full Text] [Related]

  • 14. Validation of a sensitive HPLC/fluorescence method for assessment of ciprofloxacin levels in plasma and prostate microdialysate samples from rats.
    Zimmermann ES, Torres BG, Dalla Costa T.
    Biomed Chromatogr; 2016 Mar 10; 30(3):330-6. PubMed ID: 26140501
    [Abstract] [Full Text] [Related]

  • 15. Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.
    Stass H, Nagelschmitz J, Kappeler D, Sommerer K, Kietzig C, Weimann B.
    J Aerosol Med Pulm Drug Deliv; 2017 Feb 10; 30(1):53-63. PubMed ID: 27448179
    [Abstract] [Full Text] [Related]

  • 16. Ciprofloxacin and norfloxacin pharmacokinetics and prostatic fluid penetration in dogs after multiple oral dosing.
    Albarellos GA, Montoya L, Waxman S, Kreil V, Ambros LA, Hallu R, Rebuelto M.
    Vet J; 2006 Sep 10; 172(2):334-9. PubMed ID: 15994101
    [Abstract] [Full Text] [Related]

  • 17. Diurnal variation in P-glycoprotein-mediated transport and cerebrospinal fluid turnover in the brain.
    Kervezee L, Hartman R, van den Berg DJ, Shimizu S, Emoto-Yamamoto Y, Meijer JH, de Lange EC.
    AAPS J; 2014 Sep 10; 16(5):1029-37. PubMed ID: 24917180
    [Abstract] [Full Text] [Related]

  • 18. P-glycoprotein protein expression versus functionality at the blood-brain barrier using immunohistochemistry, microdialysis and mathematical modeling.
    De Lange ECM, Vd Berg DJ, Bellanti F, Voskuyl RA, Syvänen S.
    Eur J Pharm Sci; 2018 Nov 01; 124():61-70. PubMed ID: 30144528
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of enrofloxacin following intravenous administration to greater rheas: a preliminary study.
    de Lucas JJ, Rodríguez C, Martella MB, Lábaque MC, Navarro JL, San Andrés MI.
    Res Vet Sci; 2005 Jun 01; 78(3):265-7. PubMed ID: 15766947
    [Abstract] [Full Text] [Related]

  • 20. Impact of efflux transporters and of seizures on the pharmacokinetics of oxcarbazepine metabolite in the rat brain.
    Clinckers R, Smolders I, Michotte Y, Ebinger G, Danhof M, Voskuyl RA, Della Pasqua O.
    Br J Pharmacol; 2008 Dec 01; 155(7):1127-38. PubMed ID: 18836479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.